| Authors: |
Dadashian EL; Hematology Branch, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, Maryland., McAuley EM; Hematology Branch, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, Maryland., Liu D; Office of Biostatistics Research, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland., Shaffer AL 3rd; Lymphoid Malignancies Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Young RM; Lymphoid Malignancies Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Iyer JR; Hematology Branch, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, Maryland., Kruhlak MJ; Experimental Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Staudt LM; Lymphoid Malignancies Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Wiestner A; Hematology Branch, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, Maryland., Herman SEM; Hematology Branch, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, Maryland. Sarah.Herman@nih.gov. |